A phase III trial of bevacizumab with IV versus IP chemotherapy for ovarian, fallopian tube, and peritoneal carcinoma: An NRG Oncology StudyJoan L. Walker,Mark F. Brady,P.A. DiSilvestro,Keiichi Fujiwara,D.S. Alberts,Wenxin Zheng,Krishnansu S. Tewari,David E. Cohn,M.A. Powell,L. Van Le,Stephen C. Rubin,S.A. Davidson,Heidi J. Gray,S. Waggoner,T.K.N. Myers,C. Aghajanian,Angeles Alvarez Secord,Robert S. MannelGynecologic Oncology(2016)引用 17|浏览31暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要